Biologics day
Presenters' biographies - (PDF 260 kb)
Individual presentations
Introduction - David Brennan - (PDF 231 kb)
AstraZeneca R&D: Faster, Leaner, Better - John Patterson - (PDF 161 kb)
The New MedImmune - David Mott - (PDF 601 kb)
MedImmune R&D Overview - James Young - (PDF 243 kb)
Antibody & Protein Therapeutics - Peter Kiener - (PDF 586 kb)
Vaccine Discovery - George Kemble - (PDF 181 kb)
Process Development - Gail Wasserman - (PDF 566 kb)
Infectious Disease & Pediatric Vaccines - Genevieve Losonsky - (PDF 301kb)
Oncology - Dirk Reitsma - (PDF 829 kb)
Respiratory & Inflammatory Dieseases - Barbara White - (PDF 744 kb)
Commercial Overview: RSV & Vaccines - Peter Greenleaf - (PDF 473 kb)
6 November 2007
Credit Suisse - 7th Annual Pharma Conference
Presented by
David Brennan - Chief Executive Officer
19 September 2007
Citigroup SRI meeting
Access to medicines - (PDF 1,226 kb)
Clinical trials - (PDF 1,250 kb)
Diseases of the Developing World - (PDF 1,605 kb)
Sales and marketing practices - (PDF 1,312 kb)
Pharmaceuticals in the environment - (PDF 1,154 kb)
26 July 2007
Second quarter and half year results 2007
23 April 2007
Annual General Meeting 2007
Presenters
David Brennan – Chief Executive Officer
23 April 2007
First quarter results 2007 & MedImmune acquisition
Presenters
David Brennan – Chief Executive Officer
Jon Symonds – Chief Financial Officer
John Patterson – Executive Director Development
1 February 2007
Fourth quarter and full year results 2006
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At Nov 21, 2009 10:43 AM GMT
Detailed share priceStock symbol - AZN
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
